Segments - Operations and Assets for Operating Segments and Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Jan. 01, 2021	Jan. 01, 2020
Segment Reporting Information [Line Items]
Total revenues	$ 401,332	$ 385,813	$ 442,408	$ 545,165	$ 494,676	$ 428,064	$ 301,207	$ 211,466	$ 1,774,718	$ 1,435,413	$ 901,935
Operating income (loss)									18,750	57,714	(274,052)
Depreciation and amortization									78,716	85,362	93,807
Loss from investment in investees									(629)	(480)	(2,900)
Assets	2,399,715				2,473,063				2,399,715	2,473,063
Goodwill	520,601				680,602				520,601	680,602		$ 718,625	$ 709,963
U.S.
Segment Reporting Information [Line Items]
Total revenues									1,640,354	1,317,766	751,099
Ireland
Segment Reporting Information [Line Items]
Total revenues									32,809	43,920	81,170
Chile
Segment Reporting Information [Line Items]
Total revenues									63,798	44,153	33,642
Spain
Segment Reporting Information [Line Items]
Total revenues									22,682	16,932	18,747
Israel
Segment Reporting Information [Line Items]
Total revenues									3,563	4,251	8,769
Mexico
Segment Reporting Information [Line Items]
Total revenues									11,005	7,865	8,032
Other
Segment Reporting Information [Line Items]
Total revenues									507	526	476
Corporate, Non-Segment
Segment Reporting Information [Line Items]
Operating income (loss)									(60,266)	(37,689)	(41,631)
Depreciation and amortization									0	0	59
Loss from investment in investees									0	0	0
Assets	46,672				28,080				46,672	28,080
Goodwill	0				0				0	0
Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)									(19,051)	(43,519)	(109,062)
Depreciation and amortization									26,427	29,001	30,073
Loss from investment in investees									(629)	(480)	(2,900)
Assets	1,114,460				1,176,245				1,114,460	1,176,245
Goodwill	237,576				245,793				237,576	245,793
Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)									98,067	138,922	(123,359)
Depreciation and amortization									52,289	56,361	63,675
Loss from investment in investees									0	0	0
Assets	1,238,583				1,268,738				1,238,583	1,268,738
Goodwill	$ 283,025				$ 434,809				283,025	434,809
Services
Segment Reporting Information [Line Items]
Total revenues									1,607,106	1,262,242	716,434
Services | Corporate, Non-Segment
Segment Reporting Information [Line Items]
Total revenues									0	0	0
Services | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues									0	0	0
Services | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues									1,607,106	1,262,242	716,434
Products
Segment Reporting Information [Line Items]
Total revenues									141,770	119,952	112,184
Products | Corporate, Non-Segment
Segment Reporting Information [Line Items]
Total revenues									0	0	0
Products | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues									141,770	119,952	112,184
Products | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues									0	0	0
Revenue from transfer of intellectual property and other
Segment Reporting Information [Line Items]
Total revenues									25,842	53,219	73,317
Revenue from transfer of intellectual property and other | Corporate, Non-Segment
Segment Reporting Information [Line Items]
Total revenues									0	0	796
Revenue from transfer of intellectual property and other | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues									25,842	36,979	72,521
Revenue from transfer of intellectual property and other | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues									$ 0	$ 16,240	$ 0